This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of bioactive molecules. It serves as a key intermediate in the creation of compounds that target neurological disorders, such as depression, anxiety, and other central nervous system conditions. Its structure, featuring a bromo-fluorophenyl group and a cyclopropyl moiety, makes it valuable for designing selective ligands for receptors in the brain. Additionally, it is explored in the development of potential antipsychotic and antidepressant drugs due to its ability to modulate neurotransmitter systems. Researchers also investigate its use in organic synthesis to build complex molecules with therapeutic potential.